Evotec's Horizon Savings Beat the Clock, but Deutsche Bank Won't Buy the 2030 Story
Record Mine Output Masks a Shrinking Gold Supply as Central Banks Step Up
UniCredit Holds Capital Buffer Steady as Orlopp Backs Value Case for Commerzbank Tie-Up
Berkshire's Buyback Brake: Price Discipline Meets a Weaker Underwriting Quarter
BioNTech Puts Its Cash to Work as Pipeline Delivers Mixed Readouts
Commerzbank's Record Nine-Month Haul Faces a Two-Front Test
Vertiv Locks Down Chip Supply as Its Order Book Runs at Triple-Digit Growth
Healthineers Puts Four New Board Names Forward as Olyrian Carve-Out and Siemens Split Take Shape
ABB's Robotics Sale Hits a Chinese Wall, and the Bill Comes Due
Sanofi Signals Appetite for Bigger Deals as Analysts Lift Targets
Apple's $7.5 Billion Bond Lands as Wall Street Rewrites Its Profit Math
IBM's Quantum Bet Meets Its Auditor as Cloud and AI Tools Roll Out
IREN's $20.3 Billion Order Book Has No Penalty Clause for Late Delivery
Shell Offloads Australian Shelf Stake for $1.45 Billion as Buyback and LNG Deals Roll On
Aixtron's Order Book Is Doing the Talking While the Chip Sector Sets the Volume
BASF's Evonik Stance Hardens as Analysts Tweak Targets and Buyback Rolls On
OHB's Order Book Meets Its Earnings Test: Sentinel-3 Option, Hera Milestones and a November Calendar
IonQ's Order Book Is Full. Its Gross Margin Is the Story Nobody Wants to Read
Argus Lifts Pfizer Target to $40 as Pipeline Wins Meet a Muted Market
CoreWeave's $129 Billion Backlog Meets Its Toughest Test: Turning Contracts Into Cash
Super Micro's $72–82 Billion AI Bet Meets a Wall Street Divide
PepsiCo Cuts 2026 Profit Growth Guidance as Gatorade Powder Push Tests Demand
Deutsche Bank's Cost Puzzle Overshadows a Lifted Revenue Bar
BMW's Zero-Margin Tightrope: Brokers Slash Targets but Refuse to Abandon Ship
DWS Sits Between a Bull and a Bear as Property Fund Curbs Add a Third Variable
Atlassian's $4.75 Billion Backlog Meets a Slower Cloud: Inside the 15% Slide
Nokia Charts AI's Network Future From Japan to North Carolina as Shares Rebound 3.5%
Rocket Lab's 16% Jump Came With the Crowd — the November 9 Print Will Show If It Can Stand Alone
AMD's Record Data-Center Quarter Is Already Banked — Wall Street Is Now Arguing About the Multiple
Redcare Pharmacy Wins on Prescriptions but Pays for It in the Share Price
Silver's Physical Cushion Meets the Fed's Shadow
SK Hynix's Locked-In Order Book Faces a Washington Stress Test
Leonardo Lifts Order Target to €29.5 Billion but Leaves Profit Guidance Untouched
Rheinmetall's Shadow and a Record Backlog: Hensoldt's Split-Screen Quarter